Stroke
Conditions
Brief summary
It is an interventional study in which 60 stroke patients were estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness , while the control group will receive neuromuscular stimulation only.
Detailed description
It is an interventional study in which 60 stroke patients will be estimated to enroll according to random allocation and divided into two groups. The experimental group will receive neuromuscular stimulation and mindfulness, while the control group will receive neuromuscular stimulation only. The experimental group participants will receive neuromuscular electrical stimulation that will last 12 consecutive weeks, three sessions per week protocol with Mindfulness.
Interventions
OTHERneuromuscular stimulation and mindfulness
Receive neuromuscular stimulation and mindfulness breathing; the experimental group participants will receive neuromuscular electrical stimulation with Mindfulness.
OTHERneuromuscular electrical stimulation
participants in the control group perceived neuromuscular electrical stimulation
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* The subject selection will be according to the following criteria: * All Patients of this study will be diagnosed as stroke and the diagnosis will be confirmed by computed tomography or MRI (El-Tamawy et al., 2021). * Age of patients will be ranged from 50 to 65years (males and females). * All patients will be hemodynamically stable. * Patients with good cognition that enables them to understand the requirements of the study.
Exclusion criteria
* • The potential participants will be excluded if they meet one of the following criteria: * Patients who cannot follow instructions as sensory aphasia, blindness, dementia, and deafness. * Patients with any orthopedic, neurological, or chest disorders that affect trunk muscles control or cause respiratory disorders as COPD. * Patients with cognitive and psychiatric disorders. * Patients with unstable cardiovascular conditions. * Patients with contraindications to neuro electrical stimulation as: * Cardiac pace maker. * Acute abdominal surgery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| ventilatory function | 12 weeks | By a spirometer, forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), the ratio of forced vital capacity to forced expiratory volume (FEV1/FVC), and peak expiratory flow will be measured. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| level of stress | 12 weeks | perceived stress questionnaire Individual scores on the perceived stress questionnaire can range from 0 to 40 with higher scores indicating higher perceived tress |
| Functional independence measure | 12 weeks | The Functional independence measure consists of 18 measures organized into six dimensions and ranges from 18 to 126 |
| level of physical function | 12 weeks | short physical performance battery group of measures that combines the results of the gait speed, chair stand and balance tests |
Countries
Egypt
Contacts
CONTACTmarwa elsayed, PhD
PRINCIPAL_INVESTIGATORmarwa elsayed
Cairo University
Outcome results
None listed